Experiences of mothers who legally terminate a pregnancy due to fetal congenital defects

Raquel Fernández-Heredia1, Kathy Ayde Champutiz-Quintana2, Marcos Camacho-Ávila3

  • 1Delivery Room Service, Hospital la Inmaculada, Huercal-Overa, Almeria, Spain.

Women & Health
|May 19, 2025
PubMed

The legal termination of a pregnancy due to congenital defects is a complex and emotionally intense that significantly impacts the mother's personal life and causes considerable psychological distress for both parents. Despite its clinical and ethical implications, there is limited qualitative research exploring the lived experiences of women undergo this process. This study aimed to explore and understand the experiences of mothers who have legally terminated a pregnancy due to fetal congenital defects. A qualitative study was conducted based on Gadamer's philosophical hermeneutics. Eleven semi-structured in-depth interviews were conducted between February and March 2023 in Spain. Participants were selected through purposive sampling. Interviews were audio-recorded, transcribed verbatim and analyzed inductively to identify emerging themes. Three main themes emerged from the data: 1) The painful diagnosis of a congenital fetal defect and the moral dilemma of terminating a wanted pregnancy; 2) The internal conflict and distressing experience of undergoing legal pregnancy termination; 3) The dual emotional wound resulting from pregnancy loss. Participants described the diagnosis as an emotional shock and reported feeling unsupported both during and after the process, highlighting critical gaps in psychosocial care. The findings reveal that legal termination of pregnancy due to fetal congenital defects has a profound emotional impact on mothers, who experience not only perinatal grief but also social invisibility and insufficient psychological support. These results emphasize the need to implement comprehensive, empathetic, and multidisciplinary care protocols to support women throughout the decision-making and grieving process.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
51.6K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
41.5K